Picture of Kadant logo

KAI — Kadant News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsBalancedMid CapHigh Flyer

Kadant Q2 revenue beats expectations, maintains annual revenue, profit guidance

Overview

Kadant Q2 rev falls 7% yr/yr but beats analyst expectations, per LSEG data

Adjusted EPS for Q2 beats consensus despite 18% decline, per LSEG data

Co's bookings rise 7% to $269 mln

Outlook

Kadant expects 2025 revenue of $1.020 bln to $1.040 bln

Kadant maintains 2025 adjusted EPS guidance of $9.05 to $9.25

Kadant sees Q3 2025 revenue of $256 mln to $263 mln

Company expects stable demand for aftermarket parts to continue

Co expects "stronger" bookings in the second half of 2025

Result Drivers

BOOKINGS GROWTH - Co attributes 7% increase in bookings to customer preference for its equipment and technologies, per CEO Jeffrey Powell

CASH FLOW IMPROVEMENT - Operating cash flow rose 44% and free cash flow increased 58%, indicating efficient operational management

GROSS MARGIN INCREASE - Gross margin improved by 150 basis points to 45.9%, reflecting better cost management

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 RevenueBeat$255 mln$250.40 mln (4 Analysts)
Q2 Adjusted EPSBeat$2.31$2.08 (4 Analysts)
Q2 EPS$2.22
Q2 Net Income$26 mln
Q2 Adjusted EBITDABeat$52 mln$49.20 mln (4 Analysts)
Q2 Gross Margin45.9%
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell" The average consensus recommendation for the industrial machinery & equipment peer group is "buy" Wall Street's median 12-month price target for Kadant Inc is $327.50, about 5% below its July 28 closing price of $344.02 The stock recently traded at 35 times the next 12-month earnings vs. a P/E of 33 three months ago Press Release: ID:nGNXb0lW4C (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Kadant

See all news